$1.25 Million EBITDA | Fast Growing & High-Margin Hospitalist Group | | Asset-Light & Scalable Across U.S.
Asset-Light Hospitalist Group with 41% EBITDA Margins and National Scalability
On NextCompany since August 27, 2026 (today)
FL areaEstablished 2017
Business overview
Physician-led hospitalist care covers acute hospitals, SNFs, rehabilitation centers, and LTAC facilities in Central Florida. Revenue grew from $1.73 million in 2023 to $2.62 million in 2025. Projected 2026 revenue reaches $3,000,000 with $1,250,000 EBITDA. The asset-light model requires no office leases or equipment investments. Four physicians and six advanced-practice staff remain with the group. The founder seeks a strategic partner to scale operations.
Who is a good fit for this business
- Strategic hospital groups acquire this asset-light hospitalist platform for geographic expansion.
- Financial sponsors scale a 2017-founded group with recurring facility contracts across the U.S.
- Physician-led organizations add high-margin inpatient care capabilities to existing networks.
Details
- Reason for selling
- The founder is seeking a strategic or financial partner to help scale the business and capitalize on emerging growth opportunities.
- Real estate
- No real estate
Frequently Asked Questions
The group provides 24/7 inpatient care in Central Florida across acute-care hospitals, SNFs, rehabilitation centers, and LTAC hospitals. Established facility contracts support operations.
Revenue grew from $1.73 million in 2023 to $2.62 million in 2025. Projected 2026 revenue reaches $3 million with $1.25 million EBITDA. The lean model avoids capital expenditures.
The team includes four physicians plus six advanced-practice, clinical-management, and support personnel. All staff members are expected to remain after the transaction.
The founder pursues a strategic or financial partner to scale the business. The seller remains open to a majority equity sale while retaining up to 20 percent equity.
The asking price is $10,000,000. The platform offers recurring contracts and high EBITDA margins above 40 percent with no real estate included.